# Trade Mark Journal No.2026/006 6 February 2026

## WO0000001897237 (5,42,44)

Office of origin: United States of America

Date of International Registration:5 December 2025
Date of designation in the UK: 5 December 2025

The mark consists of a cage design.

International priority date claimed: 27 June 2025 (United States of America) (99256538)

Class 5
  Pharmaceutical preparations for the treatment of neurological disorders.
Class 42
  Research and development in the field of biotechnology.
Class 44
  Providing healthcare information.

XENON PHARMACEUTICALS INC.

Representative: Makiko Coffland Christensen O'Connor Johnson Kindness, 1201 Third Avenue, Suite 3600, Seattle WA 98101, UNITED STATES OF AMERICA